ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder

NCT01098435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Binge Eating Disorder

Interventions

DRUG: RDC-0313 (ALKS 33)
DRUG: Placebo

Sponsor

Alkermes, Inc.